Elanco Animal Health (ELAN) Cash from Financing Activities (2017 - 2026)
Elanco Animal Health's Cash from Financing Activities history spans 9 years, with the latest figure at -$18.0 million for Q4 2025.
- On a quarterly basis, Cash from Financing Activities rose 43.75% to -$18.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$275.0 million, a 81.57% increase, with the full-year FY2025 number at -$275.0 million, up 81.57% from a year prior.
- Cash from Financing Activities hit -$18.0 million in Q4 2025 for Elanco Animal Health, up from -$153.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for ELAN hit a ceiling of $231.0 million in Q3 2021 and a floor of -$1.3 billion in Q3 2024.
- Historically, Cash from Financing Activities has averaged -$109.4 million across 5 years, with a median of -$75.5 million in 2021.
- Biggest five-year swings in Cash from Financing Activities: skyrocketed 344.44% in 2021 and later tumbled 10100.0% in 2022.
- Tracing ELAN's Cash from Financing Activities over 5 years: stood at $44.0 million in 2021, then crashed by 290.91% to -$84.0 million in 2022, then tumbled by 65.48% to -$139.0 million in 2023, then soared by 76.98% to -$32.0 million in 2024, then soared by 43.75% to -$18.0 million in 2025.
- Business Quant data shows Cash from Financing Activities for ELAN at -$18.0 million in Q4 2025, -$153.0 million in Q3 2025, and -$156.0 million in Q2 2025.